Somnomed
Home
Products
The SomnoDent
®
MAS Product Guide
Additional Features
Advantages of using the SomnoDent
®
MAS
Continuous Positive Airway Pressure (CPAP)
Surgery
SomnoMed MATRx
About SomnoMed
Background on Obstructive Sleep Apnea (OSA)
Development of the SomnoDent
®
MAS
A multidisciplinary approach to product delivery
Global Executive Management
Investors Information
Board of Directors
Careers at SomnoMed
ASX Announcement Q2 2011
ASX Announcement Q1 2011
ASX Announcement Archive
ASX Announcements Q3 2011
ASX Announcements Q2 2010
ASX Announcements Q1 2010
ASX Announcements Q4 2011
Articles
Media
Contact Us
Specialist Login
Specialist Resources
Specialist Educational Videos
Benefits of the Preferred Dental Network
Online Payment
Special Promotions
Partners
Country:
Australia
USA
Europe
What is OSA?
Do you suffer from OSA?
Is it right for me?
Testimonials
FAQ's
Patient Resources
Sleep Specialists
Clinical Description
How does the device work?
MAS GOLD STANDARD
Specialist Resources
Dental Sleep Professionals
Obstructive Sleep Apnea
Clinical Description
Is my patient suitable?
How does the device work?
The George Gauge™
Become a DSP
Dentist Resources
Online Payment
Preferred Dental Network
Home Sleep Diagnostics
Medical Insurance Billing
Clinical Research
Influence of Nasal Resistance
Oral appliances
Oral appliance therapy
Dental appliance treatment
Use of flow volume curves
Position paper
Comparison of a custom made
Oral appliances for OSA
Practice parameters
Treatment of snoring and OSA
Case control study
OA therapy reduces blood pressure
Effect of oral appliance therapy
Effect of vertical dimension
An individually adjustable oral appliance
4-year follow-up of treatment
Oral appliance therapy improves symptoms
A randomised, controlled study
Maxillary Expansion
Latest News at SomnoMed
Investors Information
Board of Directors
Home
|
About SomnoMed
|
ASX Announcement Archive
| ASX Announcements Q3 2011
Print Page
Email Page
ASX Announcements Q3 2011
24/03/2011
Change in substantial holding
(239.5 kb)
28/02/2011
Investor presentation
(1.4 mb)
24/02/2011
Half Yearly Report and Accounts
(68.4 kb)